SGRY on Nasdaq
Surgery Partners
In its 2026 annual report the company says: “We are a leading healthcare services company with an integrated outpatient delivery model focused on providing high-quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. We are one of the largest and fastest growing surgical services businesses in the United States, with more than 200 locations in 30 states, including ambulatory surgery centers, short-stay surgical hospitals, and multi-specialty physician practices, among others.”6 It is headquartered in Nashville, United States.1 Its shares trade on Nasdaq under the symbol SGRY.1
Price unavailable
Last updated Oct 21, 2026.
Overview
Compare with Ardent Health Services, Community Health Systems or Universal Health Services, or pick any stock.
- TickerSGRY on Nasdaq1
- Industryhealth care industry1
- HeadquartersNashville, United States1
- Websitesurgerypartners.com
- Incorporated inDE4
- Business address340 Seven Springs Way, Suite 600, Brentwood, Tn4
- Filer categoryLarge accelerated filer4
- Legal formCorporation3
- LEI549300LC82HG33S19I033
- StatusActive3
- LEI statusLapsed (not renewed)3
- Registered addressC/O CORPORATION SERVICE COMPANY, 19808 Wilmington, United States3
- Registered withDivision of Corporations, Department of State, 57221383
See how the biggest companies compare on our leaderboards
We are a leading healthcare services company with an integrated outpatient delivery model focused on providing high-quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. We are one of the largest and fastest growing surgical services businesses in the United States ("U.S."), with more than 200 locations in 30 states, including ambulatory surgery centers ("ASCs"), short-stay surgical hospitals ("surgical hospitals"), and multi-specialty physician practices, among others. Patient services provided in our ASCs and surgical hospitals (collectively, "surgical facilities" or "facilities") generated approximately $3.2 billion in revenue during 2025.6 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
11.8%Operating margin7
-2.4%Net margin7
6.2%Revenue growth, 20257
-4.5%Return on equity7
2.18×Debt to equity7
$195.6MFree cash flow7
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Private Insurance brought in 51% of the revenue Surgery Partners broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2023 | 2024 | 2025 |
|---|---|---|---|
| Private Insurance | $1.4B | $1.6B | $1.7B |
| Government Revenue | $1.1B | $1.3B | $1.4B |
| Self-Pay Revenue | $68.1M | $82.3M | $87.6M |
| Other Services | $42.9M | $59.9M | $82.4M |
| Other Patient Service Revenue Sources | $85.6M | $81.1M | $71.2M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Other costs99¢$3.3B
- Income tax1¢$18.0M
Out of $3.3B in revenue.7 The company lost money this year.
Where each dollar of operating cash went, fiscal 2025
- Capital spending29¢$78.7M
- Kept or used elsewhere71¢$195.6M
Out of $274.3M of cash from operations.7
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.7
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenues | $3.3B | $3.1B | $2.7B |
| Salaries and benefits | $971.0M | $907.5M | $793.8M |
| Supplies | $878.9M | $812.9M | $745.0M |
| Professional and medical fees | $404.5M | $357.1M | $296.8M |
| Lease expense | $87.9M | $89.5M | $84.9M |
| Other operating expenses | $201.4M | $201.7M | $175.3M |
| Cost of revenues | $2.5B | $2.4B | $2.1B |
| General and administrative expenses | $118.2M | $138.7M | $120.9M |
| Depreciation and amortization | $176.0M | $152.6M | $118.1M |
| Transaction and integration costs | $73.9M | $100.1M | $61.7M |
| Net loss on disposals, consolidations and deconsolidations | $30.4M | $40.6M | $14.4M |
| Equity in earnings of unconsolidated affiliates | -$22.9M | -$19.5M | -$14.2M |
| Litigation settlements | $7.3M | -$800.0K | $10.6M |
| Loss on debt extinguishment | $1.3M | $5.1M | $15.5M |
| Other income, net | -$8.7M | -$20.0M | -$7.5M |
| Total operating expenses | $2.9B | $2.8B | $2.4B |
| Operating income | $389.5M | $348.8M | $328.0M |
| Interest expense, net | -$272.6M | -$201.7M | -$193.0M |
| Income before income taxes | $116.9M | $147.1M | $135.0M |
| Income tax (expense) benefit | -$18.0M | -$134.6M | $300.0K |
| Net income | $98.9M | $12.5M | $135.3M |
| Less: Net income attributable to non-controlling interests | -$176.8M | -$180.6M | -$147.2M |
| Net loss attributable to Surgery Partners, Inc. | -$77.9M | -$168.1M | -$11.9M |
| Basic (in USD per share) | -$0.61 | -$1.33 | -$0.09 |
| Diluted (in USD per share) | -$0.61 | -$1.33 | -$0.09 |
| Basic (shares) | 127.2M shares | 126.1M shares | 125.6M shares |
| Diluted (shares) | 127.2M shares | 126.1M shares | 125.6M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.7
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $239.9M | $269.5M | ||
| Accounts receivable | $602.2M | $579.1M | ||
| Inventories | $96.6M | $88.4M | ||
| Prepaid expenses | $41.1M | $36.4M | ||
| Other current assets | $170.9M | $146.0M | ||
| Total current assets | $1.2B | $1.1B | ||
| Property and equipment, net | $1.2B | $1.1B | ||
| Intangible assets, net | $41.0M | $45.7M | ||
| Goodwill | $5.2B | $5.1B | $4.3B | |
| Investments in and advances to affiliates | $234.0M | $215.4M | ||
| Right-of-use operating lease assets | $289.2M | $295.7M | ||
| Other long-term assets | $56.8M | $57.5M | ||
| Total assets | $8.1B | $7.9B | ||
| Accounts payable | $208.7M | $208.7M | ||
| Accrued payroll and benefits | $64.9M | $60.4M | ||
| Other current liabilities | $242.6M | $253.9M | ||
| Current maturities of long-term debt | $99.3M | $101.4M | ||
| Total current liabilities | $615.5M | $624.4M | ||
| Long-term debt, less current maturities | $3.6B | $3.3B | ||
| Right-of-use operating lease liabilities | $279.9M | $292.1M | ||
| Long-term deferred tax liabilities | $53.4M | $39.2M | ||
| Other long-term liabilities | $41.2M | $30.2M | ||
| Non-controlling interestsredeemable | $395.5M | $438.8M | $327.4M | |
| Preferred stock, $0.01 par value; shares authorized - 20,310,000; shares issued or outstanding - none | $0 | $0 | ||
| Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 129,321,144 and 127,109,383, respectively | $1.3M | $1.3M | ||
| Additional paid-in capital | $2.5B | $2.5B | ||
| Accumulated other comprehensive (loss) income | -$13.8M | $4.8M | ||
| Retained deficit | -$815.2M | -$737.3M | ||
| Total Surgery Partners, Inc. stockholders' equity | $1.7B | $1.8B | ||
| Non-controlling interestsnon-redeemable | $1.4B | $1.4B | ||
| Total stockholders' equity | $3.1B | $3.2B | $3.0B | $2.9B |
| Total liabilities and stockholders' equity | $8.1B | $7.9B | ||
| Preferred stock, par value (in USD per share) | $0.01 | $0.01 | ||
| Preferred stock, shares authorized (shares) | 20.3M shares | 20.3M shares | ||
| Preferred stock, shares issued (shares) | 0 shares | 0 shares | ||
| Preferred stock, shares outstanding (shares) | 0 shares | 0 shares | ||
| Common stock, par value (in USD per share) | $0.01 | $0.01 | ||
| Common stock, shares authorized (shares) | 300.0M shares | 300.0M shares | ||
| Common stock, shares issued (shares) | 129.3M shares | 127.1M shares | ||
| Common stock, shares outstanding (shares) | 129.3M shares | 127.1M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $239.9M | $269.5M | ||
| Accounts receivable | $602.2M | $579.1M | ||
| Inventories | $96.6M | $88.4M | ||
| Prepaid expenses | $41.1M | $36.4M | ||
| Other current assets | $170.9M | $146.0M | ||
| Total current assets | $1.2B | $1.1B | ||
| Property and equipment, net | $1.2B | $1.1B | ||
| Intangible assets, net | $41.0M | $45.7M | ||
| Goodwill | $5.2B | $5.1B | $4.3B | |
| Investments in and advances to affiliates | $234.0M | $215.4M | ||
| Right-of-use operating lease assets | $289.2M | $295.7M | ||
| Other long-term assets | $56.8M | $57.5M | ||
| Total assets | $8.1B | $7.9B | ||
| Accounts payable | $208.7M | $208.7M | ||
| Accrued payroll and benefits | $64.9M | $60.4M | ||
| Other current liabilities | $242.6M | $253.9M | ||
| Current maturities of long-term debt | $99.3M | $101.4M | ||
| Total current liabilities | $615.5M | $624.4M | ||
| Long-term debt, less current maturities | $3.6B | $3.3B | ||
| Right-of-use operating lease liabilities | $279.9M | $292.1M | ||
| Long-term deferred tax liabilities | $53.4M | $39.2M | ||
| Other long-term liabilities | $41.2M | $30.2M | ||
| Non-controlling interestsredeemable | $395.5M | $438.8M | $327.4M | |
| Preferred stock, $0.01 par value; shares authorized - 20,310,000; shares issued or outstanding - none | $0 | $0 | ||
| Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 129,321,144 and 127,109,383, respectively | $1.3M | $1.3M | ||
| Additional paid-in capital | $2.5B | $2.5B | ||
| Accumulated other comprehensive (loss) income | -$13.8M | $4.8M | ||
| Retained deficit | -$815.2M | -$737.3M | ||
| Total Surgery Partners, Inc. stockholders' equity | $1.7B | $1.8B | ||
| Non-controlling interestsnon-redeemable | $1.4B | $1.4B | ||
| Total stockholders' equity | $3.1B | $3.2B | $3.0B | $2.9B |
| Total liabilities and stockholders' equity | $8.1B | $7.9B | ||
| Preferred stock, par value (in USD per share) | $0.01 | $0.01 | ||
| Preferred stock, shares authorized (shares) | 20.3M shares | 20.3M shares | ||
| Preferred stock, shares issued (shares) | 0 shares | 0 shares | ||
| Preferred stock, shares outstanding (shares) | 0 shares | 0 shares | ||
| Common stock, par value (in USD per share) | $0.01 | $0.01 | ||
| Common stock, shares authorized (shares) | 300.0M shares | 300.0M shares | ||
| Common stock, shares issued (shares) | 129.3M shares | 127.1M shares | ||
| Common stock, shares outstanding (shares) | 129.3M shares | 127.1M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.7
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income | $98.9M | $12.5M | $135.3M |
| Depreciation and amortization | $176.0M | $152.6M | $118.1M |
| Non-cash lease expense | $37.8M | $38.9M | $35.2M |
| Non-cash interest expense, net | $9.6M | $6.5M | $25.0M |
| Equity-based compensation expense | $14.8M | $33.3M | $17.7M |
| Net loss on disposals, consolidations and deconsolidations | $30.4M | $40.6M | $14.4M |
| Loss on debt extinguishment | $1.3M | $5.1M | $15.5M |
| Deferred income taxes | $16.7M | $131.5M | -$1.7M |
| Equity in earnings of unconsolidated affiliates, net of distributions received | -$800.0K | -$2.0M | -$2.2M |
| Accounts receivable | -$53.8M | -$72.1M | -$47.2M |
| Other operating assets and liabilities | -$56.6M | -$46.8M | -$16.3M |
| Net cash provided by operating activities | $274.3M | $300.1M | $293.8M |
| Purchases of property and equipment | -$78.7M | -$90.4M | -$88.8M |
| Payments for acquisitions, net of cash acquired | -$162.1M | -$378.8M | -$80.0M |
| Proceeds from disposals of facilities and other assets | $46.5M | $2.6M | $25.8M |
| Purchases of equity investments | -$13.3M | -$1.7M | -$50.3M |
| Proceeds from sales of equity investments | $1.5M | $4.6M | $1.4M |
| Other investing activities | -$40.5M | -$24.8M | -$33.7M |
| Net cash used in investing activities | -$246.6M | -$488.5M | -$225.6M |
| Principal payments on long-term debt | -$1.0B | -$1.3B | -$807.1M |
| Borrowings of long-term debt | $1.2B | $1.7B | $826.6M |
| Payments of debt issuance costs | -$4.1M | -$14.9M | -$24.3M |
| Distributions to non-controlling interest holders | -$226.0M | -$170.5M | -$146.1M |
| Proceeds (payments) related to ownership transactions with non-controlling interest holders | $600.0K | $9.6M | $8.2M |
| Other financing activities | $9.4M | -$12.6M | -$12.5M |
| Net cash (used in) provided by financing activities | -$57.3M | $262.0M | -$155.2M |
| Net (decrease) increase in cash and cash equivalents | -$29.6M | $73.6M | -$87.0M |
| Interest paid, net of interest income received | $256.8M | $199.7M | $169.6M |
| Cash paid for income taxes | $1.2M | $1.6M | $1.4M |
| Non-cash purchases of property and equipment | $14.2M | $12.9M | $18.0M |
No quarter-by-quarter statement was filed.
Corporate structure
Surgery Partners sits at the top of its group. 340 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of Surgery Partners
- GLENVIEW CAPITAL MANAGEMENT, LLC Filed SCHEDULE 13G on Surgery Partners, latest Oct 13, 2026
- KING STREET CAPITAL MANAGEMENT, L.P. Filed SCHEDULE 13G on Surgery Partners, latest Aug 14, 2026 (2 filings since Nov 14, 2025)
- Pentwater Capital Management LP Filed SCHEDULE 13G/A on Surgery Partners, latest May 15, 2026 (4 filings since Aug 14, 2025)
- FMR LLC Filed SCHEDULE 13G/A on Surgery Partners, latest May 6, 2026 (7 filings since Feb 9, 2022)
- VANGUARD GROUP INC Filed SCHEDULE 13G/A on Surgery Partners, latest Mar 27, 2026 (3 filings since Feb 9, 2023)
- Janus Henderson Group Ltd. Filed SCHEDULE 13G/A on Surgery Partners, latest Nov 14, 2025 (4 filings since Jan 30, 2025)
- Wellington Management Company Filed SCHEDULE 13G/A on Surgery Partners, latest Aug 12, 2025 (6 filings since Feb 6, 2023)
- BCPE Seminole Holdings LP Filed SCHEDULE 13D/A on Surgery Partners, latest Jun 17, 2025 (7 filings since Nov 15, 2021)
- BlackRock Filed SCHEDULE 13G/A on Surgery Partners, latest Apr 29, 2025 (3 filings since Oct 24, 2024)
- Durable Capital Partners LP Filed SC 13G/A on Surgery Partners, latest Feb 13, 2023 (2 filings since Dec 5, 2022)
- Clearbridge Investments, LLC Filed SC 13G/A on Surgery Partners, latest Feb 9, 2022
- Surgery Partners Nashville, Tennessee, United States
- Mountain View Hospital, LLC Idaho Falls, Idaho, United States
- A&S Management, LLC Subsidiary · Delaware, United States
- Advanced Surgery Center, LLC Subsidiary · Nebraska, United States
- Akron Vascular Care, LLC Subsidiary · Ohio, United States
- Alaska Digestive Center, LLC Subsidiary · Alaska, United States
- AllCare Holdco PC Subsidiary · North Carolina, United States
- Ambulatory Resource Centres Investment Company, LLC Subsidiary · Delaware, United States
- Ambulatory Resource Centres of Washington, LLC Subsidiary · Tennessee, United States
- Ambulatory Resource Centres of Wilmington, LLC Subsidiary · Tennessee, United States
- Ambulatory Surgery Center of Burley, LLC Subsidiary · Idaho, United States
- Anderson & Shapiro Eye Surgeons, S.C. Subsidiary · Wisconsin, United States
- Anesthesiology Professional Services, Inc. Subsidiary · Florida, United States
- Animas Anesthesia Associates, LLC Subsidiary · Colorado, United States
- Animas Surgical Hospital, LLC Subsidiary · Delaware, United States
- APS of Jonesboro, LLC Subsidiary · Delaware, United States
- ARC Development, LLC Subsidiary · Tennessee, United States
- ARC Financial Services, LLC Subsidiary · Tennessee, United States
- ARC Kentucky, LLC Subsidiary · Tennessee, United States
- ARC of Bellingham, L.P. Subsidiary · Tennessee, United States
- ARC of Georgia, LLC Subsidiary · Tennessee, United States
- Armenia Ambulatory Surgery Center, LLC Subsidiary · Florida, United States
- ASC Gamma Partners, Ltd. Subsidiary · Florida, United States
- Bahamas Surgery Center, LLC Subsidiary · California, United States
- Baton Rouge Anesthesia Services, LLC Subsidiary · Delaware, United States
- Bayside Endoscopy Center, LLC Subsidiary · Rhode Island, United States
- and 314 more
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What Surgery Partners reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Finance-lease assets | $740.4M7 Dec 31, 2025 | $655.6M7 Dec 31, 2024 | +12.9% |
| Operating-lease assets (leased space) | $289.2M7 Dec 31, 2025 | $295.7M7 Dec 31, 2024 | −2.2% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $239.9M7 Dec 31, 2025 | $269.5M7 Dec 31, 2024 | −11.0% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | $5.2B7 Dec 31, 2025 | $5.1B7 Dec 31, 2024 | +2.5% |
| Intangible assets, net (excluding goodwill) | $41.0M7 Dec 31, 2025 | $45.7M7 Dec 31, 2024 | −10.3% |
| Indefinite-lived intangibles (excluding goodwill) | $5.1M7 Dec 31, 2025 | $6.7M7 Dec 31, 2024 | −23.9% |
| Finite-lived intangibles, gross | $83.4M7 Dec 31, 2025 | $80.4M7 Dec 31, 2024 | +3.7% |
| Accumulated amortization | $47.5M7 Dec 31, 2025 | $41.4M7 Dec 31, 2024 | +14.7% |
| Finite-lived intangibles, net | $35.9M7 Dec 31, 2025 | $39.0M7 Dec 31, 2024 | −7.9% |
Inventory
Properties, in its own words
Our corporate headquarters is located in Brentwood, Tennessee, where we currently lease approximately 29,670 square feet of office space pursuant to an agreement with an initial term expiring January 30, 2027. Our surgical facilities typically are located on real estate leased by the partnership or limited liability company that operates the facility. Of our 176 surgical facilities, 173 utilize leased real property. These leases generally have initial terms of 10 years, but range from 2 to 15 years. Most of the leases contain options to extend the lease period for up to 10 additional years. We generally guarantee the lease obligations of the partnerships and LLCs that own our surgical facilities. We expect to be able to renew or replace a substantial majority of these leases on substantially similar terms as they come due. Most of our ASCs range in size from 8,000 to 12,000 square feet and are specifically tailored to meet the needs of physician-partners and their specialties. We believe these spaces are sufficient and adequate for our needs at this time.
Item 2 of the 10-K filed Mar 2, 2026.6
Leadership
Who has led Surgery Partners, and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
Chief operating officer
20202025
- Chief executive officerJason Eric Evans Mar 17, 2020 to now16
- Chief executive officerWayne DeVeydt Jan 8, 2018 to Mar 19, 201917
- Chief executive officerClifford G. Adlerz Sep 11, 2017 to Mar 20, 201818
- Chief executive officerMichael Thomas Doyle Sep 30, 2015 to Apr 4, 201719
- ChairWayne DeVeydt Feb 7, 2020 to now20
- PresidentJustin Robert Oppenheimer Jan 9, 2026 to now21
- PresidentHarrison R. Bane Nov 1, 2022 to Jan 9, 202622
- PresidentBradley R. Owens Jan 20, 2021 to Jun 3, 202423
- PresidentCarollee Brinkman Mar 19, 2019 to Mar 19, 201924
- PresidentAnthony Taparo Apr 25, 2018 to Apr 3, 201925
- Chief financial officerDavid T. Doherty Feb 3, 2022 to now26
- Chief financial officerR. David Kretschmer Feb 16, 2018 to Feb 16, 201827
- Chief financial officerThomas F. Cowhey Apr 2, 2018 to May 7, 202128
- Chief financial officerTeresa Sparks Sep 30, 2015 to Jan 3, 201829
- Chief operating officerJustin Robert Oppenheimer Jan 9, 2026 to now21
- Chief operating officerJason Eric Evans Apr 3, 2019 to Aug 21, 201930
- Chief operating officerBryan S. Fisher Aug 31, 2017 to Sep 5, 201831
Board members and other officers (30)
- Chief Human Resources OfficerDanielle Burkhalter Mar 6, 2023 to now32
- Chief Strategy OfficerMarissa Brittenham Feb 3, 2022 to now33
- Chief Human Resources OfficerLaura L. Brocklehurst Jan 20, 2021 to Nov 14, 202234
- Chief Growth OfficerAnthony Taparo Feb 7, 2020 to Mar 13, 202435
- Executive VP & CSTOR. David Kretschmer Feb 14, 2019 to Apr 3, 201936
- Chief Human Resources OfficerAngela Justice Mar 12, 2018 to Jul 3, 201937
- Pres., Ancillary Svces. Grp.Brandan Lingle Apr 25, 2018 to Apr 8, 201938
- Senior VP, OperationsRonald P. Zelhof Apr 25, 2018 to Apr 25, 201839
- CDO, Grp Pres of SPBenjamin F. Jacobs Aug 31, 2017 to Aug 31, 201740
- Chief Development OfficerSarath Degala May 26, 2016 to Oct 5, 201641
- Senior VP & ControllerDennis Dean Sep 30, 2015 to Apr 5, 201842
- Sr. VP, Gen Couns. & Sec.Jennifer Baldock Sep 30, 2015 to now43
- Group Pres., National GroupJohn Crysel Sep 30, 2015 to Jan 3, 201844
- Board memberLloyd H. Dean Mar 9, 2026 to now45
- Board memberLaura L. Forese Jan 17, 2025 to now46
- Board memberBlair E. Hendrix Nov 23, 2022 to now47
- Board memberPatricia Anne Maryland Mar 15, 2021 to now48
- Board memberJohn A. Deane May 31, 2019 to now49
- Board memberWayne DeVeydt Jan 8, 2018 to Mar 19, 201917
- Board memberClifford G. Adlerz Aug 28, 2018 to now50
- Board memberAndrew T. Kaplan Sep 10, 2018 to Dec 21, 202351
- Board memberChristopher R. Gordon Sep 1, 2017 to Sep 1, 201752
- Board memberT. Devin O'Reilly Sep 1, 2017 to Dec 21, 202353
- Board memberTeresa Deluca Sep 30, 2016 to now54
- Board memberAdam T. Feinstein Sep 30, 2015 to May 20, 201955
- Board memberChristopher Laitala Sep 30, 2015 to Apr 22, 201656
- Board memberMatthew Lozow Sep 30, 2015 to Sep 30, 201557
- Board memberMichael Thomas Doyle Sep 30, 2015 to Nov 15, 201719
- Board memberBrent Turner Dec 31, 2015 to now58
- General counselJennifer Baldock Mar 19, 2019 to Apr 3, 201959
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- A&S Management, LLC Delaware5
- APS of Jonesboro, LLC Delaware5
- ARC Development, LLC Tennessee5
- ARC Financial Services, LLC Tennessee5
- ARC Kentucky, LLC Tennessee5
- ARC of Bellingham, L.P. Tennessee5
- ARC of Georgia, LLC Tennessee5
- ASC Gamma Partners, Ltd. Florida5
- Advanced Surgery Center, LLC Nebraska5
- Akron Vascular Care, LLC Ohio5
- Alaska Digestive Center, LLC Alaska5
- AllCare Holdco PC North Carolina5
- Ambulatory Resource Centres Investment Company, LLC Delaware5
- Ambulatory Resource Centres of Washington, LLC Tennessee5
- Ambulatory Resource Centres of Wilmington, LLC Tennessee5
- Ambulatory Surgery Center of Burley, LLC Idaho5
- Anderson & Shapiro Eye Surgeons, S.C. Wisconsin5
- Anesthesiology Professional Services, Inc. Florida5
- Animas Anesthesia Associates, LLC Colorado5
- Animas Surgical Hospital, LLC Delaware5
- Armenia Ambulatory Surgery Center, LLC Florida5
- BBH Holdings of Idaho Falls, LLC Delaware5
- BSC Administrative Services Organization, LLC Delaware5
- Bahamas Surgery Center, LLC California5
All 343 listed subsidiaries
- Baton Rouge Anesthesia Services, LLC Delaware5
- Bayside Endoscopy Center, LLC Rhode Island5
- Birmingham Surgery Center, LLC Delaware5
- Blue Ridge Surgical Center, LLC Delaware5
- Bone Management MSO, LLC Delaware5
- Bristol Spine Center, LLC Delaware5
- Brooklyn SC, LLC South Carolina5
- CBSH Physicians Organization Texas5
- CBSH, LLC Texas5
- CC Pocatello, LLC Idaho5
- CCIF, LLC Delaware5
- CIPM Holdco, Inc. Georgia5
- CMSC, LLC Montana5
- Cape Coral Ambulatory Surgery Center, LLC Florida5
- Cape Coral Anesthesia Services, LLC Florida5
- Cardiac Cath Lab of Idaho Falls, LLC Delaware5
- Center For Orthopedic Surgery, LLC California5
- Chicago Prostate Cancer Surgery Center, LLC Illinois5
- Cleveland East Vascular Care, LLC Ohio5
- Cleveland West Vascular Care, LLC Ohio5
- Clinical Research Prime Idaho Falls, LLC Idaho5
- Coastal Bend Medical Park, LLC Texas5
- Coastal Bend Surgery Center, Ltd Texas5
- Cold Springs Medical Surgical Group, LLC California5
- Community Care Channing Way, LLC Delaware5
- Community Care Rexburg, LLC Delaware5
- Community Care West Side, LLC Delaware5
- Community Hospital Holding Company, LLC Georgia5
- Community Hospital Management Company, LLC Georgia5
- Coppel Surgical Solutions, LLC Nevada5
- Corpus Christi CBSC GP, Inc. Texas5
- Crescent View Surgery Center, LLC Louisiana5
- Cypress Surgery Center, LLC Delaware5
- DMG Surgical Center, LLC Illinois5
- Delaware Outpatient Center for Surgery, LLC Delaware5
- Durango Surgery Center, LLC Colorado5
- Eagle Rock Anesthesia, LLC Idaho5
- Eastside Alliance Medical Associates, P.C. New York5
- Eastside Alliance Support Services, LLC Delaware5
- El Paso Specialty Hospital, Ltd Texas5
- El Paso Specialty Physicians Group Texas5
- Eye Surgical Center of San Francisco, LLC California5
- Flagler Surgery Center, LLC Florida5
- Forest Ambulatory Surgical Associates, LLC California5
- GPDDC, LLC New York5
- Gainesville Eye Physicians, P.A. Delaware5
- Gastro Operating Company, LLC New York5
- Georgia Bone & Joint, LLC Georgia5
- Gold Coast Surgery Center, LLC California5
- Gold Coast Surgicenter, LLC Illinois5
- Gramercy Park Administrative Services, LLC Delaware5
- Grand Teton Research Group, PLLC Idaho5
- Grand Teton Surgical Center, LLC Idaho5
- Great Falls Clinic Surgery Center, L.L.C. Montana5
- Great Falls Clinic, LLC Montana5
- Great Lakes Anesthesia & Pain Specialists, S.C. Wisconsin5
- Heritage Eye Center, LC Texas5
- Hualapai Ambulatory Surgery Center, LLC Delaware5
- Humble Vascular Surgical Center, LLC Texas5
- IFSC Acquisition, LLC Delaware5
- IPM Surgery Centers, LLC California5
- Idaho Falls ASC, LLC Delaware5
- Idaho Falls Community Hospital, LLC Delaware5
- Idaho Falls Internal Medicine, LLC Idaho5
- Interventional Spine Center, LLC California5
- JW Eye Associates, PLLC Texas5
- Jacksonville Beach Surgery Center, LLC Tennessee5
- Jenkins County Hospital, LLC Georgia5
- Journey Lite of the Central Coast, LLC California5
- KW ASC Holdings, LLC Texas5
- KW SP Management, LLC Delaware5
- Kansas Spine & Specialty Hospital, LLC Kansas5
- Kent, LLC Rhode Island5
- Knowles Surgery Center, LLC California5
- La Peer Surgery Center, LLC California5
- Lafayette Surgical Hospital, LLC Louisiana5
- Lake Mary Surgery Center, L.L.C. Florida5
- Lakeway Ambulatory Surgical Center, LLC Texas5
- Lakeway Holdco, LLC Texas5
- Lakeway Stay Suites, LLC Texas5
- Laser and Outpatient Surgery Center, LLC Delaware5
- Lonestar Ambulatory Surgical Center, LLC Texas5
- Lubbock Heart Hospital, LLC Delaware5
- MV Oncology, LLC Delaware5
- MV Pocatello ENT, LLC Idaho5
- MVH BMC, LLC Idaho5
- MVH Eagle Rock ASC, LLC Idaho5
- MVH Idaho Falls Oncology, LLC Delaware5
- MVH NWSH, LLC Idaho5
- MVH PC Specialists, LLC Idaho5
- MVH PIC, LLC Idaho5
- MVH PMHS, LLC Idaho5
- MVH Parkway, LLC Delaware5
- MVH Research, LLC Idaho5
- MVH SNF Holding, LLC Idaho5
- MVH Surgical Specialists, LLC Idaho5
- MVH Valencia, LLC Idaho5
- Macon Vascular Care, LLC Georgia5
- Meadowbrook Medical Associates, LLP New York5
- Medical Center Endoscopy, LLC Texas5
- Midwest Orthopedic OrthoLazer, LLC Wisconsin5
- Midwest Orthopedic Solutions, LLC Wisconsin5
- Midwest Orthopedic Specialty Hospital, LLC Wisconsin5
- Midwest Orthopedic and Musculoskeletal Alliance, LLC Delaware5
- Midwest Surgical Hospital, LLC Nebraska5
- Midwest Uncuts, Inc. Iowa5
- Millenia Surgery Center, L.L.C. Florida5
- Minimally Invasive Surgical and Neuroscience Center, LLC Delaware5
- Montana Health Partners, LLC Montana5
- Montpelier Surgery Center, LLC Delaware5
- Mountain View Hospital, LLC Delaware5
- Mountain View Network, LLC Idaho5
- Muve - West Chester Ambulatory Surgical Center, LLC Pennsylvania5
- Muve - West Chester Stay Suites, LLC Pennsylvania5
- Muve - West Chester, LLC Pennsylvania5
- NSH Bryan Hospital, Inc. Texas5
- NSH California, LLC California5
- NSH Durham, Inc. North Carolina5
- NSH El Paso Specialty Hospital, Inc. Texas5
- NSH El Paso, Inc. Texas5
- NSH Georgia, LLC Delaware5
- NSH Louisiana, LLC Louisiana5
- NSH Management of Arizona, LLC Arizona5
- NSH Management of California, LLC California5
- NSH Mesa, LLC Arizona5
- NSH Michigan, Inc. Michigan5
- NSH North Idaho, LLC Idaho5
- NSH San Antonio Surgical Hospital, LLC Texas5
- NSH Texas, LLC Illinois5
- NSH Wisconsin, LLC Wisconsin5
- National Surgical Hospitals, LLC Delaware5
- NeoSpine Surgery, LLC Delaware5
- NorCal Orthopedic Surgery Center, LLC California5
- North Carolina Specialty Hospital, LLC North Carolina5
- North Dakota Surgery Center, LLC Delaware5
- North Idaho Day Surgery, LLC Idaho5
- North Shore Surgi-Center, Inc. New York5
- Northeast Atlanta Vascular Care, LLC Georgia5
- Northwest Ambulatory Surgery Services, LLC Washington5
- Northwest Atlanta Vascular Care, LLC Georgia5
- NovaMed Acquisition Company, LLC Delaware5
- NovaMed Eye Surgery Center of North County, LLC Delaware5
- NovaMed Eye Surgery Center of Overland Park, LLC Delaware5
- NovaMed Management Services, LLC Delaware5
- NovaMed Management of Kansas City, LLC Missouri5
- NovaMed Surgery Center of Baton Rouge, LLC Delaware5
- NovaMed Surgery Center of Chattanooga, LLC Delaware5
- NovaMed Surgery Center of Chicago-Northshore, LLC Delaware5
- NovaMed Surgery Center of Colorado Springs, LLC Delaware5
- NovaMed Surgery Center of Denver, LLC Delaware5
- NovaMed Surgery Center of Madison, Limited Partnership Wisconsin5
- NovaMed Surgery Center of Nashua, LLC Delaware5
- NovaMed Surgery Center of Orlando, LLC Delaware5
- NovaMed Surgery Center of San Antonio, L.P. Delaware5
- NovaMed Surgery Center of St. Peters, LLC Delaware5
- NovaMed Surgery Center of Tyler, L.P. Delaware5
- NovaMed Surgery Center of Warrensburg, LLC Delaware5
- NovaMed of Bethlehem, LLC Delaware5
- NovaMed of Laredo, Inc. Delaware5
- NovaMed of Lebanon, LLC Delaware5
- NovaMed of San Antonio, LLC Delaware5
- NovaMed of Texas, LLC Delaware5
- NovaMed of Wisconsin, LLC Delaware5
- NovaMed, LLC Delaware5
- NueHealth Management Services II, LLC Delaware5
- Nuehealth Equity II, LLC Delaware5
- Oak Leaf Surgery Center, LLC Wisconsin5
- Oak Leaf Surgical Hospital, LLC Wisconsin5
- Ocean State Endoscopy Holdings, LLC Rhode Island5
- Orange City Surgery Center, LLC Florida5
- Orthopedic & Spine Surgical Hospital of South Texas, LP Texas5
- Orthopedic Surgeons of Wisconsin, S.C. Wisconsin5
- Orthopedic Surgery Center of Asheville, L.P. Tennessee5
- PRG Dallas ASC, LLC Texas5
- PSC Development Company, LLC Delaware5
- PSC Operating Company, LLC Delaware5
- PSHS Alpha Partners, LLC Florida5
- PSHS Beta Partners, Ltd. Florida5
- PVG Management, LLC Delaware5
- Pain Management Associates, Inc. California5
- Park Place Surgery Center, L.L.C. Florida5
- Permian Basin Surgical Care Center, LLC Texas5
- Physicians Surgery Services, LLC Delaware5
- Plantation ASC, LLC Florida5
- Portsmouth, LLC Delaware5
- Preferred Vascular Services Akron, LLC Ohio5
- Preferred Vascular Services Cleveland West, LLC Ohio5
- Preferred Vascular Services Cleveland, LLC Ohio5
- Preferred Vascular Services Macon, LLC Georgia5
- Preferred Vascular Services Northeast, LLC Georgia5
- Preferred Vascular Services Northwest, LLC Georgia5
- Preferred Vascular Services Southeast, LLC Georgia5
- Preferred Vascular Services Southwest, LLC Georgia5
- Prescription Center Homecare, LLC Idaho5
- Prescription Center, LLC Idaho5
- Quahog Holding Company, LLC Delaware5
- Quantum Enterprises, PLLC Colorado5
- RC Eye Associates, PLLC Texas5
- Ridgewood Surgery and Endoscopy Center, LLC Delaware5
- Riverside Billing & Management Company, LLC Florida5
- Riverside Spine & Pain Physicians, LLC Florida5
- Riverside Surgical Center, LLC Florida5
- SAM Holdco PC Georgia5
- SARC/Asheville, LLC Tennessee5
- SARC/Ft. Myers, Inc. Tennessee5
- SARC/Georgia, Inc. Tennessee5
- SARC/Kent, LLC Tennessee5
- SARC/Largo Endoscopy, LLC Tennessee5
- SARC/Largo, Inc. Tennessee5
- SARC/Providence, LLC Tennessee5
- SARC/St. Charles, Inc. Tennessee5
- SCA Holdco PC Georgia5
- SCNA Holdco PC Georgia5
- SGRY Holdings, LP Tennessee5
- SGRY, LLC Delaware5
- SMBI DOCS, LLC Tennessee5
- SMBI Great Falls, LLC Tennessee5
- SMBI Havertown, LLC Tennessee5
- SMBI Idaho, LLC Tennessee5
- SMBI LHH, LLC Delaware5
- SMBI Portsmouth, LLC Tennessee5
- SMBI STLWSC, LLC Tennessee5
- SMBIMS Birmingham, LLC Tennessee5
- SMBIMS Durango, LLC Tennessee5
- SMBIMS Florida I, LLC Florida5
- SMBIMS Kirkwood, LLC Tennessee5
- SMBIMS Steubenville, Inc. Tennessee5
- SMBIMS Wichita, LLC Tennessee5
- SMBISS Beverly Hills, LLC Tennessee5
- SMBISS Chesterfield, LLC Tennessee5
- SMBISS Encino, LLC Tennessee5
- SMBISS Irvine, LLC Tennessee5
- SMBISS Thousand Oaks, LLC Tennessee5
- SP California Management, LLC Delaware5
- SP FVC, LLC Illinois5
- SP Forest Knowles Holdco, LLC Delaware5
- SP Gainesville Management, LLC Delaware5
- SP Gramercy Administrative Services Organization, LLC Delaware5
- SP Holdco I, Inc. Delaware5
- SP Irvine Holdings, LLC Delaware5
- SP Louisiana, LLC Louisiana5
- SP Management Services, Inc. Tennessee5
- SP Maury County, LLC Delaware5
- SP Mountain Management Services, LLC Delaware5
- SP New York Management, LLC Delaware5
- SP New York Support, LLC Delaware5
- SP North Dakota, LLC Delaware5
- SP North Shore Administrative Services Organization, LLC Delaware5
- SP Physician Management, LLC Delaware5
- SP Practice Management, LLC Delaware5
- SP SCH UnSub 2022 Parent, LLC Delaware5
- SP SCH UnSub 2022-1, LLC Delaware5
- SP SCH UnSub 2022-2, LLC Delaware5
- SP SCH UnSub 2022-3, LLC Delaware5
- STSSH Physicians Organization Texas5
- San Jose ASC Holdings, LLC Delaware5
- Santa Barbara ASC Holdings, LLC California5
- Sarasota Ambulatory Surgery Center, Ltd. Florida5
- Screven County Family Health Center, LLC Georgia5
- Screven County Hospital, LLC Georgia5
- Skyway Surgery Center, LLC California5
- Snake River Hospitalists, LLC Idaho5
- Southeast Atlanta Vascular Care, LLC Georgia5
- Southern Bone & Joint Ambulatory Surgical Center, LLC Georgia5
- Southpoint Surgery Center, LLC North Carolina5
- Southwest Atlanta Vascular Care, LLC Georgia5
- Southwest Endoscopy Partners, LLC Colorado5
- Space Coast Surgery Center LLC Florida5
- Specialty Surgical Center of Beverly Hills, L.P. California5
- Specialty Surgical Center of Encino, L.P. California5
- Specialty Surgical Center of Encino, LLC California5
- Specialty Surgical Center of Irvine, L.P. California5
- Specialty Surgical Center of Irvine, LLC California5
- Specialty Surgical Center, LLC California5
- St. Louis Women’s Surgery Center, LLC Delaware5
- St. Raphael's Surgery Center, LLC Texas5
- Surgery Center Holdings, Inc. Delaware5
- Surgery Center Holdings, LLC Delaware5
- Surgery Center of Fremont, LLC Delaware5
- Surgery Center of Kalamazoo, LLC Michigan5
- Surgery Center of Lebanon, LP Pennsylvania5
- Surgery Partners Acquisition Company, LLC Florida5
- Surgery Partners Insurance of Tennessee, LLC Tennessee5
- Surgery Partners of Coral Gables, LLC Florida5
- Surgery Partners of Lake Mary, LLC Florida5
- Surgery Partners of Lake Worth, LLC Florida5
- Surgery Partners of Merritt Island, LLC Florida5
- Surgery Partners of Millenia, LLC Florida5
- Surgery Partners of Park Place, LLC Florida5
- Surgery Partners of Sarasota, LLC Florida5
- Surgery Partners of West Kendall, L.L.C. Florida5
- Surgery Partners of Westchase, LLC Florida5
- Surgery Partners, LLC Florida5
- Symbion Ambulatory Resource Centres, LLC Tennessee5
- Symbion Holdings, LLC Delaware5
- SymbionARC Support Services, LLC Tennessee5
- Tampa Pain Relief Center, Inc. Florida5
- Tattnall Hospital Company, LLC Georgia5
- Texas Physicians Group Texas5
- The Center for Specialized Surgery, LP Pennsylvania5
- The Surgery Center of Ocala, LLC Tennessee5
- Tracy Surgery Center, LLC California5
- Triangle Surgery Center, LLC North Carolina5
- UCLA/SP Holdings, LLC Delaware5
- UniPhy Healthcare of Johnson City VI, LLC Tennessee5
- United ASC Holding Company, LLC Delaware5
- Universal Management, LLC Delaware5
- Universal Spine & Joint Specialists, LLC Florida5
- VASC, LLC Illinois5
- VH Naples Holdings, LLC Kansas5
- VH SEFL Holdings, LLC Kansas5
- VH Springfield Holdings, LLC Kansas5
- VH Villages Holdings, LLC Kansas5
- Valencia ASC, LLC California5
- Valley Ambulatory Surgery Center, L.P. Illinois5
- Valley Surgical Center, Ltd. Ohio5
- Village Surgicenter, LLC Delaware5
- Village Surgicenter, Limited Partnership Delaware5
- West Bloomfield Surgery Center LLC Michigan5
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Timeline
- Sep 17, 20268-K Completed an acquisition or sale60
- Aug 10, 20268-K Results of operations61
- Jul 24, 20268-K Entered a material agreement; Regulation FD disclosure62
- Jun 5, 20268-K Shareholder vote63
- May 5, 20268-K Results of operations64
- Mar 2, 20268-K Results of operations; Regulation FD disclosure65
- Dec 16, 20258-K Entered a material agreement; New debt or obligation66
- Dec 12, 20258-K Other events67
- Dec 11, 20258-K Regulation FD disclosure68
- Nov 12, 20258-K Executive or director change69
- Nov 10, 20258-K Results of operations70
- Sep 16, 20258-K Executive or director change71
- Mar 17, 2020New chief executive Jason Eric Evans becomes CEO16
- Jan 8, 2018New chief executive Wayne DeVeydt becomes CEO17
- Sep 11, 2017New chief executive Clifford G. Adlerz becomes CEO18
- Sep 30, 2015New chief executive Michael Thomas Doyle becomes CEO19
- Apr 2, 2015Founded Surgery Partners is founded3
- 2015Went public Listed on NASDAQ1
Calendar
Coming up
- Nov 9, 2026Reports results for the quarter ending Sep/2026 A year earlier it reported $0.11 a share, on Nov 10, 2025.72
When it reported results
- Aug 10, 2026Reported quarterly or annual results61
- May 5, 2026Reported quarterly or annual results64
- Mar 2, 2026Reported quarterly or annual results65
- Nov 10, 2025Reported quarterly or annual results70
- Aug 5, 2025Reported quarterly or annual results73
- May 12, 2025Reported quarterly or annual results74
- Mar 3, 2025Reported quarterly or annual results75
- Nov 12, 2024Reported quarterly or annual results76
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
454 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 52 major events, 214 insider forms, 40 large holders, 128 other. The latest 20:
- Oct 13, 2026SCHEDULE 13G EDGAR
- Sep 17, 20268-K EDGAR
- Aug 20, 20264/A EDGAR
- Aug 19, 20264 EDGAR
- Aug 14, 2026SCHEDULE 13G EDGAR
- Aug 10, 202610-Q EDGAR
- Aug 10, 20268-K EDGAR
- Jul 24, 20268-K EDGAR
- Jul 14, 20264 EDGAR
- Jun 9, 20264 EDGAR
- Jun 9, 20264 EDGAR
- Jun 9, 20264 EDGAR
- Jun 9, 20264 EDGAR
- Jun 9, 20264 EDGAR
- Jun 9, 20264 EDGAR
- Jun 9, 20264 EDGAR
- Jun 5, 20268-K EDGAR
- May 15, 2026SCHEDULE 13G/A EDGAR
- May 6, 2026SCHEDULE 13G/A EDGAR
- May 5, 202610-Q EDGAR
The 454 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
156 open-market trades by officers, directors and large owners since October 2021: 4 buys and 152 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | DeLuca TeresaDirector | Buy | 11,250 | $14.33 | $161.2K | Form 4 |
| Aug 18, 2026 | DeLuca TeresaDirector | Buy | 10,000 | $14.35 | $143.5K | Form 4 |
| Mar 16, 2026 | Doherty David TChief Financial Officer | Sale | 8,867 | $12.50 | $110.8K | Form 4 |
| Mar 16, 2026 | Evans Jason EricChief Executive Officer | Sale | 20,400 | $12.47 | $254.4K | Form 4 |
| Mar 13, 2026 | Burkhalter DanielleChief Human Resources Officer | Sale | 3,469 | $12.83 | $44.5K | Form 4 |
| Mar 13, 2026 | Brittenham MarissaChief Strategy Officer | Sale | 3,657 | $12.54 | $45.9K | Form 4 |
| Mar 12, 2026 | Baldock JenniferChief Admin & Dev Officer | Sale | 5,798 | $13.17 | $76.4K | Form 4 |
| Mar 6, 2026 | Evans Jason EricChief Executive Officer | Sale | 11,462 | $13.79 | $158.1K | Form 4 |
| Mar 6, 2026 | Doherty David TChief Financial Officer | Sale | 14,574 | $13.84 | $201.7K | Form 4 |
| Mar 6, 2026 | Baldock JenniferChief Admin & Dev Officer | Sale | 10,082 | $13.70 | $138.1K | Form 4 |
| Mar 6, 2026 | Burkhalter DanielleChief Human Resources Officer | Sale | 7,736 | $13.60 | $105.2K | Form 4 |
| Mar 6, 2026 | Webb William TrentonAmerican Group President | Sale | 272 | $13.93 | $3.8K | Form 4 |
| Mar 6, 2026 | Brittenham MarissaChief Strategy Officer | Sale | 8,785 | $13.70 | $120.4K | Form 4 |
| Mar 5, 2026 | Webb William TrentonAmerican Group President | Sale | 1,794 | $13.86 | $24.9K | Form 4 |
| Sep 4, 2025 | Bane Harrison R.National Group President | Sale | 9,339 | $22.48 | $209.9K | Form 4 |
| Aug 11, 2025 | Maryland Patricia AnneDirector | Sale | 0 | Form 4 | ||
| Aug 11, 2025 | DeLuca TeresaDirector | Sale | 20,018 | $22.74 | $455.2K | Form 4 |
| Aug 11, 2025 | Maryland Patricia AnneDirector | Sale | 20,018 | $22.74 | $455.2K | Form 4 |
| Aug 8, 2025 | Doherty David TChief Financial Officer | Sale | 47,491 | $23.39 | $1.1M | Form 4 |
| Mar 14, 2025 | Baldock JenniferChief Admin & Dev Officer | Sale | 612 | $23.94 | $14.7K | Form 4 |
All 156 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- GLENVIEW CAPITAL MANAGEMENT, LLCSCHEDULE 13G, 1 filing Oct 13, 202677
- KING STREET CAPITAL MANAGEMENT, L.P.SCHEDULE 13G, 2 filings Nov 14, 2025 to Aug 14, 202678
- Pentwater Capital Management LPSCHEDULE 13G/A, 4 filings Aug 14, 2025 to May 15, 202679
- FMR LLCSCHEDULE 13G/A, 7 filings Feb 9, 2022 to May 6, 202680
- VANGUARD GROUP INCSCHEDULE 13G/A, 3 filings Feb 9, 2023 to Mar 27, 202681
- Janus Henderson Group Ltd.SCHEDULE 13G/A, 4 filings Jan 30, 2025 to Nov 14, 202582
- Wellington Management CompanySCHEDULE 13G/A, 6 filings Feb 6, 2023 to Aug 12, 202583
- BCPE Seminole Holdings LPSCHEDULE 13D/A, 7 filings Nov 15, 2021 to Jun 17, 202584
- BlackRockSCHEDULE 13G/A, 3 filings Oct 24, 2024 to Apr 29, 202585
- Durable Capital Partners LPSC 13G/A, 2 filings Dec 5, 2022 to Feb 13, 202386
- Clearbridge Investments, LLCSC 13G/A, 1 filing Feb 9, 202287
Executive pay
What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.
| Year | Executive | Age | Salary | Total pay |
|---|---|---|---|---|
| 2025 | J. Eric EvansChief Executive Officer | 48 | $1.1M | $6.1M88 |
| 2025 | David T. DohertyExecutive Vice President and Chief Financial Officer | 53 | $666.2K | $2.7M88 |
| 2025 | Jennifer B. BaldockExecutive Vice President, Chief Administrative and Development Officer | 55 | $614.5K | $2.2M88 |
| 2025 | Harrison R. BaneFormer President, National Group | $466.3K | $1.5M88 | |
| 2025 | W. Trent WebbPresident, American Group | $510.6K | $1.3M88 | |
| 2025 | Marissa A. BrittenhamExecutive Vice President and Chief Strategy Officer | 41 | $512.1K | $1.1M88 |
| 2024 | J. Eric EvansChief Executive Officer | 48 | $1.1M | $6.5M88 |
| 2024 | David T. DohertyExecutive Vice President and Chief Financial Officer | 53 | $636.5K | $3.2M88 |
| 2024 | Jennifer B. BaldockExecutive Vice President, Chief Administrative and Development Officer | 55 | $596.2K | $2.7M88 |
| 2024 | Harrison R. BaneFormer President, National Group | $545.0K | $1.8M88 | |
| 2024 | Marissa A. BrittenhamExecutive Vice President and Chief Strategy Officer | 41 | $495.2K | $1.5M88 |
| 2023 | J. Eric EvansChief Executive Officer | 48 | $1.1M | $6.5M88 |
| 2023 | David T. DohertyExecutive Vice President and Chief Financial Officer | 53 | $567.5K | $3.5M88 |
| 2023 | Jennifer B. BaldockExecutive Vice President, Chief Administrative and Development Officer | 55 | $571.3K | $3.1M88 |
| 2023 | Marissa A. BrittenhamExecutive Vice President and Chief Strategy Officer | 41 | $470.2K | $1.7M88 |
| 2023 | Harrison R. BaneFormer President, National Group | $500.0K | $1.6M88 |
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| Bain Capital Investors LLC | 49,946,972 | $839.1M | 17.4% | No change |
| Jupiter Topco LLC | 13,882,155 | $233.2M | 0.1% | New |
| Pentwater Capital Management LP | 11,630,000 | $195.4M | 1.6% | −1,025,000 |
| UBS Group AG | 8,573,413 | $144.0M | 0.0% | −1,618,368 |
| BlackRock, Inc. | 6,241,503 | $104.9M | 0.0% | +580,715 |
| King Street Capital Management, L.P. | 6,058,141 | $101.8M | 53.7% | −4,171,589 |
| Dimensional Fund Advisors LP | 4,943,713 | $83.1M | 0.0% | −352,698 |
| Clearbridge Investments, LLC | 3,823,179 | $64.2M | 0.1% | −294,877 |
| Vanguard Portfolio Management LLC | 3,737,712 | $62.8M | 0.0% | +109,281 |
| Vanguard Capital Management LLC | 3,509,535 | $59.0M | 0.0% | +78,740 |
| Davidson Kempner Capital Management LP | 3,336,464 | $56.1M | 1.4% | No change |
| Hsbc Holdings PLC | 2,958,912 | $48.9M | 0.0% | +1,043,244 |
| Fmr LLC | 2,149,009 | $36.1M | 0.0% | −42,456 |
| State Street Corp | 2,140,905 | $36.0M | 0.0% | +187,127 |
| Geode Capital Management, LLC | 2,116,579 | $35.6M | 0.0% | +114,205 |
| Nomura Holdings Inc | 1,525,108 | $25.6M | 0.1% | +801,868 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1,471,492 | $24.7M | 0.0% | −117,876 |
| LMR Partners LLP | 1,360,587 | $22.9M | 0.2% | +260,587 |
| Morgan Stanley | 1,232,751 | $20.7M | 0.0% | +220,574 |
| Bank Of America Corp /de/ | 1,212,766 | $20.4M | 0.0% | −27,216 |
| Victory Capital Management Inc | 1,083,812 | $18.2M | 0.0% | +323,471 |
| Charles Schwab Investment Management Inc | 1,081,600 | $18.2M | 0.0% | −25,650 |
| Goldman Sachs Group Inc | 1,079,626 | $18.1M | 0.0% | −200,926 |
| Hein Park Capital Management LP | 1,068,621 | $18.0M | 35.7% | New |
| Varde Management, L.P. | 1,003,447 | $16.9M | 25.1% | +248,009 |
13F reports cover disclosed long positions in U.S. stocks only.
SEC filer profile
How Surgery Partners is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARSurgery Partners, Inc.2
- CIK0001638833
- Employer ID (EIN)47-36209236
- Filer statusLarge accelerated filer not an emerging growth company; not a smaller reporting company; not a shell company6
- Incorporated inDelaware6
- Fiscal year endsDecember 312
- Industry code (SIC)8062 Services-General Medical & Surgical Hospitals, NEC2
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance2
- Business address340 Seven Springs Way, Suite 600, Brentwood, TN2
- Phone615-234-59002
- Shares outstanding130,918,260 as of Aug 3, 202613
- Public float$2.6B as of Jun 30, 20256
- AuditorErnst & Young LLP, Nashville, Tennessee PCAOB ID 42; it also attests to the company’s internal control over financial reporting6
- On EDGAR sinceApr 22, 20152
- Filings841 in all: 4 (372), 8-K (140), 144 (99), 3 (41), 10-Q (33), SC 13G/A (18), SCHEDULE 13G/A (14), UPLOAD (13)2
All 38 form types
SC 13G (12), 10-K (11), CORRESP (11), DEF 14A (11), DEFA14A (8), SC 13D/A (8), 424B5 (6), SCHEDULE 13G (6), ARS (4), S-8 (4), 4/A (2), 424B7 (2), 8-K/A (2), DEF 14C (2), DRS/A (2), DRSLTR (2), EFFECT (2), PRE 14C (2), S-1/A (2), SCHEDULE 13D/A (2), 424B4 (1), 8-A12B (1), CERTNAS (1), DRS (1), FWP (1), NT 10-K (1), S-1 (1), S-3 (1), S-3ASR (1), SC 13D (1)
- Latest filingsAnnual report (10-K) Mar 2, 2026
Quarterly report (10-Q) Aug 10, 2026
Proxy statement (DEF 14A) Apr 23, 2026
Latest 8-K (8-K) Sep 17, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common Stock, par value $0.01 per share | SGRY | The Nasdaq Global Select Market |
From the cover page of the 10-K filed Mar 2, 2026 (Section 12(b) of the Exchange Act).6
Risk factors and legal proceedings
The risks Surgery Partners names in Item 1A of its 10-K filed Mar 2, 2026: 41 risks under these headings, as written.6
- Business and Operational Risks
- Financial and Accounting Risks
- Cybersecurity and Data Risks
- Legal and Regulatory Risks
- Governance Risks
- We depend on payments from third-party payors, including government health care programs and private insurance organizations. If these payments are reduced or eliminated, our revenue and profitability could be materially and adversely affected.
- If we are unable to negotiate and enter into favorable contracts or maintain satisfactory relationships and renew existing contracts on favorable terms with private insurance payors, our revenue and profitability may decrease.
- Significant changes in our payor mix or surgical case mix resulting from fluctuations in the types of cases performed at our facilities could have a material adverse effect on our business, prospects, results of operations and financial condition.
- Our ability to provide medical services at our facilities would be impaired and our revenue reduced if we are not able to maintain good relationships with affiliated physicians who utilize our surgical facilities.
- Our growth strategy depends in part on our ability to integrate operations of acquired surgical facilities, attract new physician partners, and to acquire and develop additional surgical facilities on favorable terms. If we are unable to achieve any of these goals, our future growth could be limited and our operating results could be adversely affected.
- Shortages of surgery-related products, equipment and medical supplies and quality control issues with such products, equipment and medical supplies could disrupt our operations and adversely affect our case volume, surgical case mix and profitability.
- We face competition from other health care facilities and providers.
The other 34 risks
- Competition for physicians and clinical personnel, including nurses, shortages of qualified personnel or other factors could increase our labor costs and adversely affect our revenue, profitability and cash flows.
- Our surgical facilities are sensitive to regulatory, economic and other conditions in the states where they are located.
- Certain of our partnership and operating agreements contain provisions giving rights to our partners and other members that may be adverse to our interests.
- We may have a special legal responsibility to the holders of ownership interests in the entities through which we own our facilities, which may conflict with, and prevent us from acting solely in, our own best interests or the interests of our stockholders.
- Growth of patient receivables or deterioration in the ability to collect on these accounts, due to changes in economic conditions or otherwise, could have a material adverse effect on our business, prospects, results of operations and financial condition.
- If we are unable to integrate and operate our information systems effectively or implement new systems and processes, our operations could be disrupted.
- A pandemic, epidemic or outbreak of a contagious disease in the markets in which we operate or that otherwise impacts our facilities could adversely impact our business.
- We have a history of net losses and may not achieve or sustain profitability in the future.
- Our leverage could adversely affect our ability to raise additional capital to fund our operations, limit our ability to react to changes in the economy or our industry, expose us to interest rate risk to the extent of our variable rate debt and prevent us from meeting our obligations under our outstanding indebtedness.
- To service our indebtedness, we will require a significant amount of cash. Our ability to generate cash depends on many factors beyond our control, and any failure to meet our debt service obligations may adversely affect our business, financial condition and results of operations.
- Restrictive covenants in our debt instruments may adversely affect us.
- Despite our current indebtedness levels, we and our subsidiaries may still be able to incur more debt, which could further exacerbate the risks associated with our leverage.
- We are a holding company with no operations of our own.
- We make significant loans to, and are generally liable for debts and other obligations of, the partnerships and limited liability companies that own and operate some of our surgical facilities.
- Our variable rate indebtedness subjects us to interest rate risk, which could cause our indebtedness service obligations to increase significantly.
- We may be limited in our ability to utilize, or may not be able to utilize, net operating loss carryforwards to reduce our future tax liability.
- Cybersecurity attacks or intrusions could adversely impact our businesses.
- Our use and disclosure of personally identifiable information, including health information, is subject to federal and state privacy and security regulations, and our failure to comply with those regulations or to adequately secure the information we hold could result in significant liability or reputational harm.
- We cannot predict the effect that changes in healthcare laws, regulations, policies and government programs may have on our business, financial condition or results of operations.
- If we fail to comply with or otherwise incur liabilities under the numerous federal and state laws and regulations relating to the operation of our facilities, we could incur significant penalties or other costs or be required to make significant changes to our operations.
- If regulations change, we may be obligated to purchase some or all of the ownership of our physician partners or renegotiate some of our partnership and operating agreements with our physician partners and management agreements with surgical facilities.
- Our surgical facilities do not satisfy the requirements for any of the safe harbors under the federal Anti-Kickback Statute. If a federal or state agency asserts a different position or enacts new laws in this regard, we could be subject to criminal and civil penalties, loss of licenses and exclusion from governmental programs, which may result in a substantial loss of revenue.
- If we fail to comply with physician self-referral laws as they are currently interpreted or may be interpreted in the future, or if other legislative restrictions are issued, we could incur substantial monetary penalties and a significant loss of revenue.
- Federal law restricts the ability of our surgical hospitals to expand capacity.
- Companies within the health care industry, including us, continue to be the subject of federal and state audits and investigations, including actions for false and other improper claims.
- We may become involved in litigation which could negatively impact the value of our business.
- If we become subject to large malpractice or other legal claims, we could be required to pay significant damages, which may not be covered by insurance.
- Failure to comply with Medicare’s conditions for coverage and conditions of participation may result in loss of program payment or other governmental sanctions.
- Our facilities could face decreased Medicare payments if they fail to report and meet various quality metrics.
- State efforts to regulate the construction, acquisition or expansion of health care facilities could prevent us from acquiring additional surgical facilities, renovating our existing facilities or expanding the breadth of services we offer.
- If antitrust enforcement authorities conclude that our market share in any particular market is too concentrated, that our or our health system partners’ commercial payor contract negotiating practices are illegal, or that we other violate antitrust laws, we could be subject to enforcement actions that could have a material adverse effect on our business, prospects, results of operations and financial condition.
- Our largest stockholder has significant influence over us, including influence over decisions that require the approval of stockholders, which could limit our stockholders’ ability to influence the outcome of key transactions, including a change of control.
- Provisions in our charter documents and Delaware law may deter takeover efforts that could be beneficial to stockholder value.
- Our amended and restated certificate of incorporation designates courts in the State of Delaware as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers or employees.
Legal proceedings
We are, from time to time, subject to claims and suits, or threats of claims or suits, relating to our business, including claims for damages for personal injuries, breach of management contracts and employment-related claims. In certain of these actions, plaintiffs request payment for damages, including punitive damages, which may not be covered by insurance or may otherwise have a material adverse effect on our business or results of operations. In the opinion of management, we are not currently a party to any proceedings that would have a material adverse effect on our business, financial condition or results of operations.
The opening of Item 3, Legal Proceedings.6
Links
- Websitesurgerypartners.com1
- X (Twitter)x.com/SurgeryPartners1
- LinkedInwww.linkedin.com/company/surgery-partners-inc1
- WikidataQ124668353
- SEC EDGARCIK 1638833
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataSurgery Partners on Wikidata
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20SEC EDGARWayne DeVeydt, Chair
- 21SEC EDGARJustin Robert Oppenheimer, President
- 22SEC EDGARHarrison R. Bane, President
- 23SEC EDGARBradley R. Owens, President
- 24SEC EDGARCarollee Brinkman, President
- 25SEC EDGARAnthony Taparo, President
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35SEC EDGARAnthony Taparo, Chief Growth Officer
- 36
- 37
- 38
- 39
- 40
- 41
- 42SEC EDGARDennis Dean, Senior VP & Controller
- 43
- 44
- 45SEC EDGARLloyd H. Dean, Board member
- 46SEC EDGARLaura L. Forese, Board member
- 47SEC EDGARBlair E. Hendrix, Board member
- 48SEC EDGARPatricia Anne Maryland, Board member
- 49SEC EDGARJohn A. Deane, Board member
- 50SEC EDGARClifford G. Adlerz, Board member
- 51SEC EDGARAndrew T. Kaplan, Board member
- 52SEC EDGARChristopher R. Gordon, Board member
- 53SEC EDGART. Devin O'Reilly, Board member
- 54SEC EDGARTeresa Deluca, Board member
- 55SEC EDGARAdam T. Feinstein, Board member
- 56SEC EDGARChristopher Laitala, Board member
- 57SEC EDGARMatthew Lozow, Board member
- 58SEC EDGARBrent Turner, Board member
- 59SEC EDGARJennifer Baldock, General counsel
- 60SEC EDGARCompleted an acquisition or sale
- 61SEC EDGARResults of operations
- 62
- 63SEC EDGARShareholder vote
- 64SEC EDGARResults of operations
- 65
- 66
- 67SEC EDGAROther events
- 68SEC EDGARRegulation FD disclosure
- 69SEC EDGARExecutive or director change
- 70SEC EDGARResults of operations
- 71SEC EDGARExecutive or director change
- 72NasdaqNasdaq calendar
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88